Decent Value Stocks. Analyze the stocks with a good fundamental valuation, while still showing decent profitability, health and growth.
BMY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 197 industry peers in the Pharmaceuticals industry. While BMY has a great profitability rating, there are some minor concerns on its financial health. BMY is valued quite cheap, while showing a decent growth score. This is a good combination! BMY also has an excellent dividend rating. These ratings could make BMY a good candidate for value and dividend investing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 5.86% | ||
ROE | 31.16% | ||
ROIC | 14.88% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 27.11% | ||
PM (TTM) | 11.38% | ||
GM | 74.69% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 2.67 | ||
Debt/FCF | 3.8 | ||
Altman-Z | 2.07 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.28 | ||
Quick Ratio | 1.17 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 6.38 | ||
Fwd PE | 7.56 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 7.29 | ||
EV/EBITDA | 6.29 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 5.28% |